Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
M.PunjaR.et al (2025)
A previous CSP analysis using FOXO4 FHD titration of 15 N-labeled p53 TAD showed that significant perturbations two standard deviations above average were mostly observed in residues within the p53 TAD2 region 38
UK and KE led the writing
This method is consistent with how we handle the percent of low-wage and high-wage workers at a firm
Until the FDA issues specific guidance defining the comparability standard for autologous C&G therapies (a process that will require substantial scientific input from industry, academia, and patient advocacy groups), the BPCIA pathway for C&G therapy biosimilars remains operationally undefined
US$ 21.66
US$ 27.45
US$ 29.39
US$ 22.18
US$ 20.05
US$ 23.30
US$ 29.62
US$ 23.70
